Inhibrx Biosciences (NASDAQ:INBX) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS
Inhibrx Biosciences (NASDAQ:INBX – Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($2.11) EPS for the quarter, missing analysts’ consensus estimates of ($2.08) by ($0.03), FiscalAI reports. Inhibrx Biosciences Stock Down 6.1% Shares of NASDAQ INBX opened at $60.92 on Friday. Inhibrx Biosciences has a 52 week low of $10.81 […]
21 Mar 12:29 · The Markets Daily